Preterm birth can be severely harmful to neonates. Currently, no effective clinical treatments target in utero inflammation ...

CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...